# Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis

> **NCT04160091** · PHASE2 · TERMINATED · sponsor: **Pacira Pharmaceuticals, Inc** · enrollment: 19 (actual)

## Conditions studied

- Osteoarthritis of the Shoulder
- Adhesive Capsulitis

## Interventions

- **DRUG:** FX006
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT04160091
- **Lead sponsor:** Pacira Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-11-07
- **Primary completion:** 2020-06-15
- **Final completion:** 2020-06-15
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** The study was terminated prematurely due to the COVID-19 pandemic creating uncertainty impacting trial progress and costs.
- **Last updated:** 2024-01-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04160091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04160091, "Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04160091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*